A S Shah Selected Research

beta-adrenergic receptor kinase inhibitory peptide

11/2001	Right ventricular gene therapy with a beta-adrenergic receptor kinase inhibitor improves survival after pulmonary artery banding.
3/2001	In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.
5/2000	Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A S Shah Research Topics

Disease

3	Weight Loss (Weight Reduction) 10/2017 - 01/2017
2	Idiopathic Pulmonary Fibrosis 01/2017 - 11/2011
2	Myocardial Infarction 03/2001 - 05/2000
1	Morbid Obesity 10/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2017
1	Skin Neoplasms (Skin Cancer) 01/2017
1	Cognitive Dysfunction 01/2017
1	Cystic Fibrosis (Mucoviscidosis) 01/2017
1	Dementia (Dementias) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Obesity 01/2017
1	Carcinoma (Carcinomatosis) 04/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2013
1	Primary Graft Dysfunction 11/2011
1	Reperfusion Injury 11/2011
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2011
1	Renal Insufficiency (Renal Failure) 03/2009
1	Meningitis 03/2009
1	Atrial Fibrillation 04/2007
1	Multiple Myeloma 01/2005
1	Lethargy 11/2001
1	Hypertrophy 11/2001
1	Left Ventricular Dysfunction 03/2001
1	Ventricular Dysfunction 03/2001
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 08/2000
1	Myocardial Stunning (Stunned Myocardium) 06/2000
1	Heart Failure 05/2000
1	Respiratory Acidosis 05/2000
1	Hemorrhage 05/2000
1	Hemorrhagic Shock 05/2000
1	Ischemia 03/2000

Drug/Important Bio-Agent (IBA)

3	beta-adrenergic receptor kinase inhibitory peptideIBA 11/2001 - 05/2000
2	Apolipoproteins E (ApoE)IBA 01/2017 - 01/2017
2	beta-Adrenergic Receptor KinasesIBA 11/2001 - 03/2001
2	beta Adrenergic ReceptorsIBA 08/2000 - 05/2000
1	LipidsIBA 10/2017
1	ApolipoproteinsIBA 01/2017
1	HDL LipoproteinsIBA 01/2017
1	Anaplastic Lymphoma KinaseIBA 04/2013
1	Phosphotransferases (Kinase)IBA 04/2013
1	Proteins (Proteins, Gene)FDA Link 04/2013
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 04/2013
1	Prostaglandins DIBA 11/2011
1	Calcineurin InhibitorsIBA 03/2009
1	AntigensIBA 03/2009
1	LatexIBA 03/2009
1	AmmoniaIBA 01/2005
1	Calcitonin Gene-Related PeptideIBA 06/2000
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2000
1	Oxygen (Dioxygen)IBA 05/2000
1	MaltoseIBA 05/2000
1	Hemoglobins (Hemoglobin)IBA 05/2000
1	pyridoxalated-hemoglobin-polyethylene glycol conjugateIBA 05/2000

Therapy/Procedure

2	Lung Transplantation 01/2017 - 11/2011
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2017
1	Kidney Transplantation 03/2009
1	Electric Countershock (Cardioversion) 04/2007
1	Drug Therapy (Chemotherapy) 01/2005
1	Resuscitation 05/2000
1	Solid-State Lasers 03/2000